Douglas S. Micalizzi, Ph.D. - Publications

2009 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Molecular Biology, Oncology

10/17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Towers CG, Guarnieri AL, Micalizzi DS, Harrell JC, Gillen AE, Kim J, Wang CA, Oliphant MU, Drasin DJ, Guney MA, Kabos P, Sartorius CA, Tan AC, Perou CM, Espinosa JM, et al. The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p. Nature Communications. 6: 10077. PMID 26687066 DOI: 10.1038/ncomms10077  0.88
2012 Iwanaga R, Wang CA, Micalizzi DS, Harrell JC, Jedlicka P, Sartorius CA, Kabos P, Farabaugh SM, Bradford AP, Ford HL. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways. Breast Cancer Research : Bcr. 14: R100. PMID 22765220 DOI: 10.1186/bcr3219  0.88
2012 Wang CA, Jedlicka P, Patrick AN, Micalizzi DS, Lemmer KC, Deitsch E, Casás-Selves M, Harrell JC, Ford HL. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. The Journal of Clinical Investigation. 122: 1895-906. PMID 22466647 DOI: 10.1172/JCI59858  0.88
2012 Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, Tan AC, Ford HL. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene. 31: 5162-71. PMID 22286770 DOI: 10.1038/onc.2012.11  0.88
2012 Farabaugh SM, Micalizzi DS, Jedlicka P, Zhao R, Ford HL. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties. Oncogene. 31: 552-62. PMID 21706047 DOI: 10.1038/onc.2011.259  0.88
2010 Micalizzi DS, Wang CA, Farabaugh SM, Schiemann WP, Ford HL. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth. Cancer Research. 70: 10371-80. PMID 21056993 DOI: 10.1158/0008-5472.CAN-10-1354  0.88
2010 Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. Journal of Mammary Gland Biology and Neoplasia. 15: 117-34. PMID 20490631 DOI: 10.1007/s10911-010-9178-9  0.88
2009 Micalizzi DS, Ford HL. Epithelial-mesenchymal transition in development and cancer. Future Oncology (London, England). 5: 1129-43. PMID 19852726 DOI: 10.2217/fon.09.94  0.88
2009 Micalizzi DS, Christensen KL, Jedlicka P, Coletta RD, Barón AE, Harrell JC, Horwitz KB, Billheimer D, Heichman KA, Welm AL, Schiemann WP, Ford HL. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. The Journal of Clinical Investigation. 119: 2678-90. PMID 19726885 DOI: 10.1172/JCI37815  0.88
2008 Coletta RD, Christensen KL, Micalizzi DS, Jedlicka P, Varella-Garcia M, Ford HL. Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation. Cancer Research. 68: 2204-13. PMID 18381426 DOI: 10.1158/0008-5472.CAN-07-3141  0.88
Low-probability matches
2020 Ebright RY, Lee S, Wittner BS, Niederhoffer KL, Nicholson BT, Bardia A, Truesdell S, Wiley DF, Wesley B, Li S, Mai A, Aceto N, Vincent-Jordan N, Szabolcs A, Chirn B, ... ... Micalizzi DS, et al. Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis. Science (New York, N.Y.). PMID 32029688 DOI: 10.1126/science.aay0939  0.01
2018 Micalizzi DS, Maheswaran S. On the trail of invasive cells in breast cancer. Nature. 554: 308-309. PMID 32094721 DOI: 10.1038/d41586-018-01634-w  0.01
2018 Micalizzi DS, Maheswaran S. On the trail of invasive cells in breast cancer. Nature. 554: 308-309. PMID 29446387 DOI: 10.1038/d41586-018-01634-w  0.01
2017 Micalizzi DS, Maheswaran S, Haber DA. A conduit to metastasis: circulating tumor cell biology. Genes & Development. 31: 1827-1840. PMID 29051388 DOI: 10.1101/gad.305805.117  0.01
2017 Micalizzi DS, Haber DA, Maheswaran S. Cancer metastasis through the prism of epithelial to mesenchymal transition in circulating tumor cells. Molecular Oncology. PMID 28544498 DOI: 10.1002/1878-0261.12081  0.01
2015 McKee KE, Etherton MR, Lovitch SB, Gupta AS, Micalizzi DS, Tierney T, Wadleigh M, Vaitkevicus H. A Man in His 40s With Headache, Lethargy, and Altered Mental Status. Jama Neurology. 72: 1061-5. PMID 26213984 DOI: 10.1001/jamaneurol.2015.1375  0.01
2003 Micalizzi DS, Dougherty JP, Noecker LA, Smith GR, Giuliano RM. Synthesis of the polyketomycin disaccharide Tetrahedron Asymmetry. 14: 3183-3188. DOI: 10.1016/j.tetasy.2003.07.023  0.01
Hide low-probability matches.